{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Rizatriptan Benzoate is a prescription medication used to treat migraine headaches. It comes as orally disintegrating tablets in 5mg and 10mg strengths, taken by mouth. As a serotonin receptor agonist, it helps relieve migraine symptoms like pain and nausea. Manufactured by Aurobindo Pharma Ltd. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Rizatriptan benzoate \u2014 ANDA 204339 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204339", "mediaType": "text/html", "title": "Rizatriptan benzoate"}], "identifier": "ANDA204339", "issued": "2016-09-16", "keyword": ["fda", "pharmaceuticals", "medications", "health-care", "drug-information"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Rizatriptan benzoate"}